Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease.

@article{Jang2014SafetyAE,
  title={Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease.},
  author={Wooyoung Eric Jang and Jinse Park and Kyung Jin Shin and Joong Seok Kim and Ji Sun Kim and Jinyoung Youn and Jin Whan Cho and Eungseok Oh and Jin Young Ahn and Ki-Wook Oh and Hee Tae Kim},
  journal={Journal of the neurological sciences},
  year={2014},
  volume={337 1-2},
  pages={47-54}
}
BACKGROUND Numerous animal studies and clinical trials have demonstrated that erythropoietin (EPO) has therapeutic effects in ischemic and degenerative diseases. However, few clinical trials have investigated the effect of EPO in Parkinson's disease (PD) patients. This study was an exploratory pilot study to investigate the effects of recombinant human EPO… CONTINUE READING